Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol. A multicenter study. The Simvastatin Study Group (Q69547243)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1989

Language	Label	Description	Also known as
English	Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol. A multicenter study. The Simvastatin Study Group	scientific article published on 01 October 1989

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol. A multicenter study. The Simvastatin Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

1 reference

based on heuristic

inferred from title

author name string

M J Tikkanen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

T S Bocanegra

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

J F Walker

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

T Cook

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 October 1989

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

87

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

4A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

47S-53S

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

Current pharmacologic treatment of elevated serum cholesterol

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

A power study of a rank transform for the two-way classification model when interaction may be present

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Efficacy and long-term adverse effect pattern of lovastatin

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(89)80599-6

7 January 2021

Identifiers

10.1016/S0002-9343(89)80599-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2679084 AND SRC:MED&resulttype=core&format=json

3 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69547243&oldid=2232346845"